Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Jun;12(3):263-87.
doi: 10.1007/BF01061721.

Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man

Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man

P H Hinderling et al. J Pharmacokinet Biopharm. 1984 Jun.

Abstract

The structure and pharmacokinetics relationship of 14-beta-adrenoceptor antagonists was investigated in humans. Statistically significant linear and parabolic correlations were found to exist between standard and derived mean pharmacokinetic parameters and the apparent octanol/buffer (pH 7.4) partition coefficient of the compounds. The lipophilic/hydrophilic properties were the primary determinants for the pharmacokinetic behavior of the compounds. Most of the pharmacokinetic parameters were also significantly correlated with the plasma protein/plasma water partition coefficient for the compounds. When the values of the pharmacokinetic parameters of the individual compounds were predicted from the regressions on the apparent partition coefficients in octanol/buffer (pH 7.4) and in plasma protein/plasma water, the error was on average 60%.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Pharmacol Ther. 1976 Oct;20(4):401-12 - PubMed
    1. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):505-10 - PubMed
    1. Br J Clin Pharmacol. 1981 Jun;11(6):549-53 - PubMed
    1. J Pharmacokinet Biopharm. 1977 Jun;5(3):193-205 - PubMed
    1. J Pharm Sci. 1971 Jun;60(6):833-9 - PubMed

Substances